The Advanced Heart failure Program is a rapidly expanding service at the front lines of treating heart failure. Launched in 1988, the program builds upon decades of experience treating failing hearts. In 2019, we performed 49 heart transplants, putting us among the top centers of the country. Our left ventricular assist device program treats more cases than any other program in the Northeast. It provides heart pumps for patients who need support while they are waiting for a donor heart or who are ineligible for a transplant and need another permanent solution. Heart transplants are the gold standard treatment for patients with end-stage heart failure. But many face a long, difficult wait for a donor heart, and some don’t survive. Yale Medicine is one of a handful of centers in the country to push existing boundaries in heart transplant by aggressively seeking out donor hearts other centers turn down even though they may be suitable for some patients. This process, using what’s called “donation after circulatory death” (DCD) organs, is helping more of our patients get heart transplants sooner. What’s more, our one-year survival rates for heart transplants—93%—are better than the national average. Multi-organ transplants People who live with heart failure have a high likelihood of also having kidney dysfunction from a variety of causes, and this can be a limiting factor in being able to get a heart transplant. For these patients, our heart specialists collaborate with Yale Medicine’s world-class abdominal transplant team and have achieved a robust volume and successful track record in performing heart-kidney transplants. Pioneers in LVAD Yale Medicine helped to pioneer the use of left ventricular assist devices (LVADs), providing patients whose hearts are too weak to function on their own with implantable devices that can pump blood for them. Yale Medicine is one of the leaders in the Northeast in volume and outcomes with LVADs and is certified by the Joint Commission, the nation’s predominant standard-setting and accrediting body in health care. Each one of our patients is treated by a team that includes cardiologists, transplant surgeons, infectious disease specialists, nephrologists, critical care doctors, nurses, pharmacists, social workers, nutritionists, and transplant coordinators, among others. Transplant doctors at Yale are national leaders in the field. Currently, the presidents of United Network for Organ Sharing (UNOS) and the American Society of Transplantation are at Yale, and they have helped to write the guidelines for how to treat patients after solid organ transplants as the field advances. Outcomes above average Patients whose future once seemed difficult have survived for decades after a heart transplant or LVAD implant. The average one-year survival after a Yale Medicine heart transplant is 93%, which is higher than the national average. This is partly due to meticulous follow-up care that includes treatment with immunosu

About Us At Yale Medicine, our cardiac surgery team consists of internationally recognized heart surgeons who provide personalized, compassionate care for adult and pediatric patients. We understand the challenges of living with a heart condition and are committed to partnering with patients and their families to find the best treatment plan and offer ongoing support after surgery. Our team includes highly experienced, board-certified cardiac surgeons along with an expert group of cardiologists, cardiac-focused nurses, physician assistants, and nurse practitioners. Our cardiac surgeons collaborate with Yale's cardiologists, vascular surgeons, and internists to manage heart-related issues such as heart failure, coronary artery disease, heart valve conditions, and heart rhythm disorders. Our surgeons perform the latest, most advanced techniques in minimally invasive and traditional surgeries to treat a full range of cardiac diseases and conditions, including: Coronary artery bypass grafting (CABG) Valve repair and replacement (aortic and mitral) Aneurysm repair (aortic, thoracic aortic, left ventricular) Arrhythmia (abnormal heart rhythm), including hybrid ablation heart failure and artificial heart or ventricular assist devices Heart failure, including artificial heart or ventricular assist devices Heart transplantation Congenital heart diseases in children and adults

Yale’s Department of Surgery is a premier center for adult and pediatric surgical treatment, providing comprehensive care for a full range of conditions and diseases. To ensure that our patients experience shorter hospital stays and less postoperative discomfort, we employ the latest technologies and surgical techniques, and perform minimally invasive surgery whenever possible. Our renowned surgeons and faculty continue to push the frontiers of surgical science through innovative treatment and leading-edge research, with the ability to offer treatment options that can be difficult to find elsewhere. More state-of-the-art surgical suites at Yale New Haven Hospital than in any other hospital in the region Collaboration with the Yale Department of Biomedical Engineering and with industry to develop 3-D bioprinting for the regeneration, repair, and replacement of human tissue and vessels Nationally recognized Center of Excellence and designated training center for transcatheter aortic valve replacement (TAVR) Yale’s Endocrine Neoplasia Laboratory is an internationally renowned multidisciplinary research group in which surgeons work with endocrine geneticists to decipher the molecular genetics of endocrine tumor disease First program in Connecticut to offer three different minimally invasive bariatric surgical techniques: Roux-en-Y gastric bypass, LAP-Band® surgery, and laparoscopic sleeve gastrectomy